These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8155403)

  • 1. Effects of menatetrenone on prednisolone-induced bone loss in rats.
    Hara K; Akiyama Y; Ohkawa I; Tajima T
    Bone; 1993; 14(6):813-8. PubMed ID: 8155403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of menatetrenone on bone loss induced by ovariectomy in rats.
    Akiyama Y; Hara K; Ohkawa I; Tajima T
    Jpn J Pharmacol; 1993 Jun; 62(2):145-53. PubMed ID: 8371513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats.
    Hara K; Kobayashi M; Akiyama Y
    Bone; 2002 Nov; 31(5):575-81. PubMed ID: 12477571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats.
    Mawatari T; Miura H; Higaki H; Moro-Oka T; Kurata K; Murakami T; Iwamoto Y
    J Bone Miner Res; 2000 Sep; 15(9):1810-7. PubMed ID: 10977000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin K2 (menatetrenone) treatment increased bone strength in rats given low-calcium diets].
    Tomiuga T; Akiyama Y; Kobayashi M; Hara K; Kawashima H
    Nihon Yakurigaku Zasshi; 1999 Nov; 114(5):303-13. PubMed ID: 10621944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis.
    Yonemura K; Kimura M; Miyaji T; Hishida A
    Calcif Tissue Int; 2000 Feb; 66(2):123-8. PubMed ID: 10652960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain.
    Hara K; Akiyama Y; Nakamura T; Murota S; Morita I
    Bone; 1995 Feb; 16(2):179-84. PubMed ID: 7756045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of vitamin K2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study.
    Akiyama Y; Hara K; Kobayashi M; Tomiuga T; Nakamura T
    Jpn J Pharmacol; 1999 May; 80(1):67-74. PubMed ID: 10446758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro.
    Hara K; Akiyama Y; Tajima T; Shiraki M
    J Bone Miner Res; 1993 May; 8(5):535-42. PubMed ID: 8511981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin K2 (menatetrenone) on calcium balance in ovariectomized rats.
    Kobayashi M; Hara K; Akiyama Y
    Jpn J Pharmacol; 2002 Jan; 88(1):55-61. PubMed ID: 11855678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of vitamin D3 on inhibitory effect of vitamin K2 on bone loss in ovariectomized rats].
    Hara K; Akiyama Y; Tomiuga T; Kobayashi M; Nakamura T; Tajima T
    Nihon Yakurigaku Zasshi; 1994 Aug; 104(2):101-9. PubMed ID: 7927067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine.
    Yonemura K; Fukasawa H; Fujigaki Y; Hishida A
    Am J Kidney Dis; 2004 Jan; 43(1):53-60. PubMed ID: 14712427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures.
    Akiyama Y; Hara K; Tajima T; Murota S; Morita I
    Eur J Pharmacol; 1994 Sep; 263(1-2):181-5. PubMed ID: 7821350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of menatetrenone on the decrease in calcium balance induced by vitamin K-deficient diet and sodium loading in rats.
    Tomiuga T; Kobayashi M; Nakajima Y; Bessho M; Katoh Y; Hara K; Akiyama Y; Nakamura T; Tajima T
    Jpn J Pharmacol; 1994 May; 65(1):35-43. PubMed ID: 8089928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.
    Kobayashi M; Hara K; Akiyama Y
    Bone; 2004 Nov; 35(5):1136-43. PubMed ID: 15542039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K2, a gamma-carboxylating factor of gla-proteins, normalizes the bone crystal nucleation impaired by Mg-insufficiency.
    Amizuka N; Li M; Kobayashi M; Hara K; Akahane S; Takeuchi K; Freitas PH; Ozawa H; Maeda T; Akiyama Y
    Histol Histopathol; 2008 Nov; 23(11):1353-66. PubMed ID: 18785118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity.
    Koshihara Y; Hoshi K; Shiraki M
    Biochem Pharmacol; 1993 Oct; 46(8):1355-62. PubMed ID: 8240383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the combined administration of risedronate and menatetrenone on bone loss induced by tacrolimus in rats.
    Kanda J; Furukawa M; Izumo N; Shimakura T; Yamamoto N; Takahashi HE; Wakabayashi H
    Drug Discov Ther; 2020; 14(2):77-83. PubMed ID: 32378649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of Menatetrenone-4 postmenopausal Thai women.
    Bunyaratavej N; Penkitti P; Kittimanon N; Boonsangsom P; Bonjongsat A; Yunoi S
    J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S553-9. PubMed ID: 11853280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide.
    Somekawa Y; Chigughi M; Harada M; Ishibashi T
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2700-4. PubMed ID: 10443663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.